Researchers may well identify a safe, effective vaccine for COVID-19 before too long, but all that fantastic work could count for nothing unless we also invest in the next stages of the vaccine process – manufacturing and delivery.
With measures to prevent the spread of COVID-19 disrupting immunisation around the globe, millions are now at risk of other deadly diseases. We must act and invest urgently to maintain routine immunisation.
During the COVID-19 pandemic, researchers and publishers have pulled together to publish their outputs at an unprecedented rate. How will this change research culture and the way findings are disseminated in future?
Julia Gillard, the former Prime Minister of Australia, has been appointed as the next Chair of Wellcome. She will will succeed Eliza Manningham-Buller, who is stepping down from the role in April 2021.
On 4 May, world leaders and health organisations pledged billions for the COVID-19 response. Alex Harris explains that urgent funding gaps remain for research.
From access to tests, treatments and vaccines for everyone to coordinating urgent action – Alex Harris shares five key messages ahead of the Coronavirus Global Response Summit.
As COVID-19 continues to spread around the world, a global community of researchers are working to find out more about the virus and assess what research needs to be done to stop it.